Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 01, 2026 Filed Aug 5, 2026 01:03 UTC |
Black Robe Capital LLC10% owner
MCNULTY JAMES AChief Financial Officer
|
GiftCommon Stock | 3,200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-036080 · ownership.xml · nonDerivative · entry 1 Black Robe Capital LLC · CIK 0001977553 · 10% owner MCNULTY JAMES A · CIK 0001275857 · Chief Financial Officer Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,901,057 Read SEC document |
| May 05, 2026 Filed Jun 1, 2026 20:15 UTC |
Vasisht NirajDirector
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-026623 · ownership.xml · nonDerivative · entry 1 Vasisht Niraj · CIK 0001662930 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,000 F1 · shares: Represents restricted common stock issued to the Reporting Person as compensation pursuant to the Issuer's 2025 Equity Incentive Plan. Read SEC document |
| May 04, 2026 Filed Jun 24, 2026 16:34 UTC |
Jerman Michael AllenDirector
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-029898 · ownership.xml · nonDerivative · entry 1 Jerman Michael Allen · CIK 0001979732 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 180,411 F1 · shares: Represents restricted common stock issued to the Reporting Person as compensation pursuant to the Issuer's 2025 Equity Incentive Plan. Read SEC document |
| May 04, 2026 Filed Aug 4, 2026 15:55 UTC |
ODONNELL FRANCIS E JRDirector · Chief Executive Officer · 10% owner
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-035950 · ownership.xml · nonDerivative · entry 1 ODONNELL FRANCIS E JR · CIK 0001066040 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 F1 · shares: Represents restricted common stock issued to the Reporting Person as compensation pursuant to the Issuer's 2025 Equity Incentive Plan, subject to shareholder approval. Read SEC document |
| May 04, 2026 Filed Aug 4, 2026 17:33 UTC |
OSMAN RONALD EDirector · 10% owner
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-035962 · ownership.xml · nonDerivative · entry 1 OSMAN RONALD E · CIK 0001380466 · Director · 10% owner Ronald E. Osman Irrevocable Trust III under Agreement dated May 13, 2012 · CIK 0001972372 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 23,614,985 F1 · shares: Represents restricted common stock issued to the Reporting Person as compensation pursuant to the Issuer's 2014 Equity Incentive Plan, subject to shareholder approval. F2 · ownership.direct: These shares represent 100,000 shares owned by Mr. Osman and remaining number of shares of common stock held by The Ronald E. Osman Trust III. Mr. Osman is the sole trustee of the Ronald E. Osman Trust III. Read SEC document |
| May 04, 2026 Filed Aug 4, 2026 16:19 UTC |
Yanez MichelleDirector
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-035955 · ownership.xml · nonDerivative · entry 1 Yanez Michelle · CIK 0001958023 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,221,271 F1 · shares: Represents restricted common stock issued to the Reporting Person as compensation pursuant to the Issuer's 2025 Equity Incentive Plan, subject to shareholder approval. Read SEC document |
| May 04, 2026 Filed Aug 4, 2026 16:15 UTC |
SEARS SAMUEL P JRDirector
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-035953 · ownership.xml · nonDerivative · entry 1 SEARS SAMUEL P JR · CIK 0001238483 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,229,543 F1 · shares: Represents restricted common stock issued to the Reporting Person as compensation pursuant to the Issuer's 2025 Equity Incentive Plan, subject to shareholder approval. Read SEC document |
| April 01, 2025 Filed Apr 7, 2025 21:25 UTC |
Yanez MichelleDirector
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-003033 · ownership.xml · nonDerivative · entry 1 Yanez Michelle · CIK 0001958023 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 896,271 F1 · shares: Represents restricted common stock issued to the Reporting Person as compensation pursuant to the Issuer's 2014 Equity Incentive Plan. Read SEC document |
| April 01, 2025 Filed Apr 7, 2025 21:23 UTC |
SEARS SAMUEL P JRDirector
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-003029 · ownership.xml · nonDerivative · entry 1 SEARS SAMUEL P JR · CIK 0001238483 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,279,543 F1 · shares: Represents restricted common stock issued to the Reporting Person as compensation pursuant to the Issuer's 2014 Equity Incentive Plan. Read SEC document |
| April 01, 2025 Filed Apr 7, 2025 21:22 UTC |
OSMAN RONALD EDirector · 10% owner
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-003025 · ownership.xml · nonDerivative · entry 1 OSMAN RONALD E · CIK 0001380466 · Director · 10% owner Ronald E Osman Irrevocable Trust III · CIK 0001972372 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 23,554,985 F1 · shares: Represents restricted common stock issued to the Reporting Person as compensation pursuant to the Issuer's 2014 Equity Incentive Plan. F2 · ownership.direct: These shares represent 100,000 shares owned by Mr. Osman and remaining number of shares of common stock held by The Ronald E. Osman Trust III. Mr. Osman is the sole trustee of the Ronald E. Osman Trust III. Read SEC document |
| April 01, 2025 Filed Apr 7, 2025 21:21 UTC |
Jerman Michael AllenDirector
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-003023 · ownership.xml · nonDerivative · entry 1 Jerman Michael Allen · CIK 0001979732 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,411 F1 · shares: Represents restricted common stock issued to the Reporting Person as compensation pursuant to the Issuer's 2014 Equity Incentive Plan. Read SEC document |
| April 01, 2025 Filed Apr 10, 2025 17:30 UTC |
Vasisht NirajDirector
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-003556 · ownership.xml · nonDerivative · entry 1 Vasisht Niraj · CIK 0001662930 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: Not disclosed F1 · shares: Represents restricted common stock issued to the Reporting Person as compensation pursuant to the Issuer's 2014 Equity Incentive Plan. Read SEC document |
| December 02, 2024 Filed Feb 20, 2025 02:28 UTC |
MCNULTY JAMES AChief Financial Officer
|
GiftCommon Stock | 1,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-007628 · ownership.xml · nonDerivative · entry 1 MCNULTY JAMES A · CIK 0001275857 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,946,135 Read SEC document |
| December 02, 2024 Filed Feb 20, 2025 02:27 UTC |
Yanez MichelleDirector
|
GiftCommon Stock | 250,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-007626 · ownership.xml · nonDerivative · entry 1 Yanez Michelle · CIK 0001958023 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,146,271 Read SEC document |
| April 01, 2024 Filed May 16, 2024 17:34 UTC |
Yanez MichelleDirector
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-020171 · ownership.xml · nonDerivative · entry 1 Yanez Michelle · CIK 0001958023 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 896,271 F1 · shares: Represents restricted common stock issued to the Reporting Person as compensation pursuant to the Issuer's 2014 Equity Incentive Plan. Read SEC document |
| April 01, 2024 Filed May 16, 2024 17:34 UTC |
OSMAN RONALD EDirector · 10% owner
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-020172 · ownership.xml · nonDerivative · entry 1 OSMAN RONALD E · CIK 0001380466 · Director · 10% owner Ronald E Osman Irrevocable Trust III · CIK 0001972372 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Seefootnote Disclosed balance after: 23,564,985 F1 · shares: Represents restricted common stock issued to the Reporting Person as compensation pursuant to the Issuer's 2014 Equity Incentive Plan. F2 · ownership.direct: These shares represent 100,000 shares owned by Mr. Osman and remaining number of shares of common stock held by The Ronald E. Osman Trust III. Mr. Osman is the sole trustee of the Ronald E. Osman Trust III. Read SEC document |
| April 01, 2024 Filed May 16, 2024 17:34 UTC |
SEARS SAMUEL P JRDirector
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-020173 · ownership.xml · nonDerivative · entry 1 SEARS SAMUEL P JR · CIK 0001238483 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,129,543 F1 · shares: Represents restricted common stock issued to the Reporting Person as compensation pursuant to the Issuer's 2014 Equity Incentive Plan. Read SEC document |
| April 01, 2024 Filed May 16, 2024 17:34 UTC |
Jerman Michael AllenDirector
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-020170 · ownership.xml · nonDerivative · entry 1 Jerman Michael Allen · CIK 0001979732 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,411 F1 · shares: Represents restricted common stock issued to the Reporting Person as compensation pursuant to the Issuer's 2014 Equity Incentive Plan. Read SEC document |
| March 16, 2024 Filed May 16, 2024 17:34 UTC |
MCNULTY JAMES ACHIEF FINANCIAL OFFICER · 10% owner
|
GrantStock Option · Derivative | 100,000 | $0.00 Strike: $0.08 | $0.00 |
DisclosureSEC source: 0001493152-24-020169 · ownership.xml · derivative · entry 1 MCNULTY JAMES A · CIK 0001275857 · CHIEF FINANCIAL OFFICER · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2034-03-16 F1 · derivative.exercise_date: The common stock options were issued to the Reporting Person on March 16, 2024 pursuant to the Issuer's 2014 Equity Incentive Plan. The common stock options vested immediately. Read SEC document |
| August 11, 2023 Filed Aug 29, 2023 19:49 UTC |
OSMAN RONALD EDirector · 10% owner
|
GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-045043 · ownership.xml · nonDerivative · entry 1 OSMAN RONALD E · CIK 0001380466 · Director · 10% owner Ronald E Osman Irrevocable Trust III · CIK 0001972372 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,514,985 F1 · price: Grant from the company for no consideration F2 · ownership.direct: These shares represent 25,000 shares owned by Mr. Osman and remaining number of shares of common stock held by The Ronald E. Osman Trust III. Mr. Osman is the sole trustee of the Ronald E. Osman Trust III. Read SEC document |
| May 05, 2023 Filed May 17, 2023 23:46 UTC |
MCNULTY JAMES ASee Remarks · 10% owner
|
OtherCommon Stock | 20,101,057 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-013201 · doc4.xml · nonDerivative · entry 3 MCNULTY JAMES A · CIK 0001275857 · See Remarks · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 26,101,057 F1 · kind: Shares of common stock of Inhibitor Therapeutics, Inc. were distributed to the members of Hedgepath, LLC ("HPLLC"), pro-rata pursuant to their membership interest in HPLLC. F2 · ownership.nature: Mr. McNulty was the manager of HPLLC, which distributed 79,627,069 shares of common stock to its members, pro-rata pursuant to their membership interest in HPLLC. Pursuant to the distribution, Mr. McNulty received 398,135 shares of common stock and Blackrobe Capital LLC received 20,101,057 shares of common stock. Mr. McNulty is the sole manager of Blackrobe Capital, LLC, but has no pecuniary interest in such shares. Read SEC document |
| May 05, 2023 Filed May 17, 2023 23:46 UTC |
MCNULTY JAMES ASee Remarks · 10% owner
|
OtherCommon Stock | 398,135 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-013201 · doc4.xml · nonDerivative · entry 2 MCNULTY JAMES A · CIK 0001275857 · See Remarks · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 946,135 F1 · kind: Shares of common stock of Inhibitor Therapeutics, Inc. were distributed to the members of Hedgepath, LLC ("HPLLC"), pro-rata pursuant to their membership interest in HPLLC. F2 · ownership.direct: Mr. McNulty was the manager of HPLLC, which distributed 79,627,069 shares of common stock to its members, pro-rata pursuant to their membership interest in HPLLC. Pursuant to the distribution, Mr. McNulty received 398,135 shares of common stock and Blackrobe Capital LLC received 20,101,057 shares of common stock. Mr. McNulty is the sole manager of Blackrobe Capital, LLC, but has no pecuniary interest in such shares. Read SEC document |
| May 05, 2023 Filed May 17, 2023 23:46 UTC |
MCNULTY JAMES ASee Remarks · 10% owner
|
OtherCommon Stock | 79,627,069 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-013201 · doc4.xml · nonDerivative · entry 1 MCNULTY JAMES A · CIK 0001275857 · See Remarks · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · kind: Shares of common stock of Inhibitor Therapeutics, Inc. were distributed to the members of Hedgepath, LLC ("HPLLC"), pro-rata pursuant to their membership interest in HPLLC. F2 · ownership.nature: Mr. McNulty was the manager of HPLLC, which distributed 79,627,069 shares of common stock to its members, pro-rata pursuant to their membership interest in HPLLC. Pursuant to the distribution, Mr. McNulty received 398,135 shares of common stock and Blackrobe Capital LLC received 20,101,057 shares of common stock. Mr. McNulty is the sole manager of Blackrobe Capital, LLC, but has no pecuniary interest in such shares. Read SEC document |
| May 05, 2023 Filed May 17, 2023 23:09 UTC |
Yanez MichelleDirector
|
OtherCommon Stock | 796,271 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-013195 · doc4.xml · nonDerivative · entry 1 Yanez Michelle · CIK 0001958023 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 800,673 F1 · kind: Shares of common stock of Inhibitor Therapeutics, Inc. were distributed to the members of Hedgepath, LLC ("HPLLC"), pro-rata pursuant to their membership interest in HPLLC. Read SEC document |
| January 15, 2021 Filed Jan 19, 2021 18:50 UTC |
Mayne Pharma Ventures Pty Ltd10% owner
Mayne Pharma International Pty Ltd10% owner
Mayne Pharma Group Ltd10% owner
|
OtherCommon Stock | 2,240,488 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-005226 · tm213575d1_4.xml · nonDerivative · entry 1 Mayne Pharma Ventures Pty Ltd · CIK 0001611535 · 10% owner Mayne Pharma International Pty Ltd · CIK 0001611534 · 10% owner Mayne Pharma Group Ltd · CIK 0001560183 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 204,083,227 F1 · kind: On January 15, 2021, Mayne Pharma Ventures Pty Ltd ("Mayne Ventures") received a dividend of 2,240,488 shares of Common Stock paid by the Issuer on shares of Series B Convertible Preferred Stock held by Mayne Ventures, pursuant to the terms of such Series B Convertible Preferred Stock. F2 · ownership.direct: These securities are directly owned by Mayne Ventures. This report is filed jointly by Mayne Ventures, Mayne Pharma International Pty Ltd ("Mayne International") and Mayne Pharma Group Limited ("Mayne Group"). Mayne Group holds 100% of the issued and outstanding equity securities of Mayne International, and Mayne International holds 100% of the issued and outstanding equity securities of Mayne Ventures. Consequently, Mayne Group and Mayne International may be deemed to beneficially own the securities that are the subject to this report indirectly, but disclaim beneficial ownership of such securities except to the extent of their pecuniary interests therein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, Mayne Ventures may be deemed to be a director by deputization by virtue of its representation on the Board of Directors of the Issuer. Read SEC document |
| December 22, 2020 Filed Dec 28, 2020 21:30 UTC |
Hasara Garrison J.CFO and Treasurer
|
GrantCommon Stock Option · Derivative | 125,000 | $0.00 Strike: $0.03 | $0.00 |
DisclosureSEC source: 0000899243-20-035203 · doc4.xml · derivative · entry 1 Hasara Garrison J. · CIK 0001510349 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2030-12-22 Read SEC document |
| December 22, 2020 Filed Dec 28, 2020 21:30 UTC |
Watson W. MarkDirector
|
GrantCommon Stock Option · Derivative | 1,306,452 | $0.00 Strike: $0.03 | $0.00 |
DisclosureSEC source: 0000899243-20-035202 · doc4.xml · derivative · entry 1 Watson W. Mark · CIK 0001612372 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,306,452 Underlying: Common Stock · 1,306,452 shares Expires 2030-12-22 Read SEC document |
| December 22, 2020 Filed Dec 28, 2020 21:30 UTC |
Ono Richard DanaDirector
|
GrantCommon Stock Option · Derivative | 754,839 | $0.00 Strike: $0.03 | $0.00 |
DisclosureSEC source: 0000899243-20-035201 · doc4.xml · derivative · entry 1 Ono Richard Dana · CIK 0001595989 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 754,839 Underlying: Common Stock · 754,839 shares Expires 2030-12-22 Read SEC document |
| December 22, 2020 Filed Dec 28, 2020 21:30 UTC |
Peattie DebraDirector
|
GrantCommon Stock Option · Derivative | 580,646 | $0.00 Strike: $0.03 | $0.00 |
DisclosureSEC source: 0000899243-20-035200 · doc4.xml · derivative · entry 1 Peattie Debra · CIK 0001792108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 580,646 Underlying: Common Stock · 580,646 shares Expires 2030-12-22 Read SEC document |
| December 22, 2020 Filed Dec 28, 2020 21:30 UTC |
VIRCA NICHOLAS JPresident and CEO
|
GrantCommon Stock Option · Derivative | 125,000 | $0.00 Strike: $0.03 | $0.00 |
DisclosureSEC source: 0000899243-20-035197 · doc4.xml · derivative · entry 1 VIRCA NICHOLAS J · CIK 0001284074 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2030-12-22 Read SEC document |
| December 22, 2020 Filed Dec 28, 2020 21:30 UTC |
Martin Robert DanielDirector
|
GrantCommon Stock Option · Derivative | 754,839 | $0.00 Strike: $0.03 | $0.00 |
DisclosureSEC source: 0000899243-20-035195 · doc4.xml · derivative · entry 1 Martin Robert Daniel · CIK 0001509322 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 754,839 Underlying: Common Stock · 754,839 shares Expires 2030-12-22 Read SEC document |
| September 17, 2020 Filed Sep 21, 2020 22:42 UTC |
VIRCA NICHOLAS JPresident and CEO
|
GrantCommon Stock Option · Derivative | 100,000 | $0.00 Strike: $0.05 | $0.00 |
DisclosureSEC source: 0000899243-20-025807 · doc4.xml · derivative · entry 1 VIRCA NICHOLAS J · CIK 0001284074 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2030-09-17 Read SEC document |
| September 17, 2020 Filed Sep 21, 2020 22:39 UTC |
Hasara Garrison J.CFO and Treasurer
|
GrantCommon Stock Option · Derivative | 100,000 | $0.00 Strike: $0.05 | $0.00 |
DisclosureSEC source: 0000899243-20-025806 · doc4.xml · derivative · entry 1 Hasara Garrison J. · CIK 0001510349 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2030-09-17 Read SEC document |
| July 15, 2020 Filed Jul 21, 2020 01:56 UTC |
Mayne Pharma Ventures Pty Ltd10% owner
Mayne Pharma International Pty Ltd10% owner
Mayne Pharma Group Ltd10% owner
|
OtherCommon Stock | 3,189,688 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-084975 · tm2025270d1_4.xml · nonDerivative · entry 1 Mayne Pharma Ventures Pty Ltd · CIK 0001611535 · 10% owner Mayne Pharma International Pty Ltd · CIK 0001611534 · 10% owner Mayne Pharma Group Ltd · CIK 0001560183 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,842,739 F1 · kind: On July 15, 2020, Mayne Pharma Ventures Pty Ltd ("Mayne Ventures") received a dividend of 3,189,688 shares of Common Stock paid by the Issuer on shares of Series B Convertible Preferred Stock held by Mayne Ventures, pursuant to the terms of such Series B Convertible Preferred Stock. F2 · ownership.direct: These securities are directly owned by Mayne Ventures. This report is filed jointly by Mayne Ventures, Mayne Pharma International Pty Ltd ("Mayne International") and Mayne Pharma Group Limited ("Mayne Group"). Mayne Group holds 100% of the issued and outstanding equity securities of Mayne International, and Mayne International holds 100% of the issued and outstanding equity securities of Mayne Ventures. Consequently, Mayne Group and Mayne International may be deemed to beneficially own the securities that are the subject to this report indirectly, but disclaim beneficial ownership of such securities except to the extent of their pecuniary interests therein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, Mayne Ventures may be deemed to be a director by deputization by virtue of its representation on the Board of Directors of the Issuer. Read SEC document |
| March 20, 2020 Filed Mar 24, 2020 13:01 UTC |
Peattie DebraDirector
|
GrantCommon Stock Option · Derivative | 1,000,000 | $0.00 Strike: $0.05 | $0.00 |
DisclosureSEC source: 0000899243-20-009310 · doc4.xml · derivative · entry 1 Peattie Debra · CIK 0001792108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000,000 Underlying: Common Stock · 1,000,000 shares Expires 2030-03-20 Read SEC document |
| March 20, 2020 Filed Mar 24, 2020 13:02 UTC |
Ono Richard DanaDirector
|
GrantCommon Stock Option · Derivative | 1,000,000 | $0.00 Strike: $0.05 | $0.00 |
DisclosureSEC source: 0000899243-20-009312 · doc4.xml · derivative · entry 1 Ono Richard Dana · CIK 0001595989 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000,000 Underlying: Common Stock · 1,000,000 shares Expires 2030-03-20 Read SEC document |
| March 20, 2020 Filed Mar 24, 2020 13:00 UTC |
Martin Robert DanielDirector
|
GrantCommon Stock Option · Derivative | 1,000,000 | $0.00 Strike: $0.05 | $0.00 |
DisclosureSEC source: 0000899243-20-009309 · doc4.xml · derivative · entry 1 Martin Robert Daniel · CIK 0001509322 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000,000 Underlying: Common Stock · 1,000,000 shares Expires 2030-03-20 Read SEC document |
| March 20, 2020 Filed Mar 24, 2020 13:00 UTC |
Watson W. MarkDirector
|
GrantCommon Stock Option · Derivative | 1,500,000 | $0.00 Strike: $0.05 | $0.00 |
DisclosureSEC source: 0000899243-20-009308 · doc4.xml · derivative · entry 1 Watson W. Mark · CIK 0001612372 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500,000 Underlying: Common Stock · 1,500,000 shares Expires 2030-03-20 Read SEC document |
| December 12, 2019 Filed Dec 16, 2019 21:32 UTC |
Peattie DebraDirector
|
GrantCommon Stock Option · Derivative | 210,000 | $0.00 Strike: $0.05 | $0.00 |
DisclosureSEC source: 0000899243-19-029254 · doc4.xml · derivative · entry 1 Peattie Debra · CIK 0001792108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,000 Underlying: Common Stock · 210,000 shares Expires 2029-12-12 Read SEC document |
| December 12, 2019 Filed Feb 10, 2020 21:20 UTC |
Watson W. MarkDirector
|
PurchaseCommon Stock | 500 | $0.06 | $30.95 |
DisclosureSEC source: 0000899243-20-003818 · doc5.xml · nonDerivative · entry 1 Watson W. Mark · CIK 0001612372 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,054,100 Read SEC document |
| December 02, 2019 Filed Dec 3, 2019 01:57 UTC |
Hasara Garrison J.CFO and Treasurer
|
PurchaseCommon Stock | 13,500 | $0.07 | $945.00 |
DisclosureSEC source: 0000899243-19-028374 · doc4.xml · nonDerivative · entry 1 Hasara Garrison J. · CIK 0001510349 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,972,544 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in two transactions at a per share price equal to $0.07 and $0.068. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| June 03, 2019 Filed Jun 10, 2019 22:27 UTC |
Watson W. MarkDirector
|
GrantCommon Stock Option · Derivative | 25,000 | $0.00 Strike: $0.07 | $0.00 |
DisclosureSEC source: 0000899243-19-016242 · doc4.xml · derivative · entry 1 Watson W. Mark · CIK 0001612372 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2029-06-03 Read SEC document |
| February 03, 2019 Filed Feb 6, 2019 00:57 UTC |
Martin Robert DanielDirector
|
GrantCommon Stock Option · Derivative | 657,895 | $0.00 Strike: $0.08 | $0.00 |
DisclosureSEC source: 0000899243-19-002714 · doc4.xml · derivative · entry 1 Martin Robert Daniel · CIK 0001509322 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 657,895 Underlying: Common Stock · 657,895 shares Expires 2029-02-03 Read SEC document |
| February 03, 2019 Filed Feb 6, 2019 00:57 UTC |
Ono Richard DanaDirector
|
GrantCommon Stock Option · Derivative | 657,895 | $0.00 Strike: $0.08 | $0.00 |
DisclosureSEC source: 0000899243-19-002715 · doc4.xml · derivative · entry 1 Ono Richard Dana · CIK 0001595989 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 657,895 Underlying: Common Stock · 657,895 shares Expires 2029-02-03 Read SEC document |
| February 03, 2019 Filed Feb 6, 2019 00:52 UTC |
MAGRAB E. BRENDANDirector
|
GrantCommon Stock Options · Derivative | 986,842 | $0.00 Strike: $0.08 | $0.00 |
DisclosureSEC source: 0000899243-19-002708 · doc4.xml · derivative · entry 1 MAGRAB E. BRENDAN · CIK 0001196062 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 986,842 Underlying: Common Stock · 986,842 shares Expires 2029-02-03 Read SEC document |
| February 03, 2019 Filed Feb 6, 2019 00:54 UTC |
Watson W. MarkDirector
|
GrantCommon Stock Option · Derivative | 657,895 | $0.00 Strike: $0.08 | $0.00 |
DisclosureSEC source: 0000899243-19-002712 · doc4.xml · derivative · entry 1 Watson W. Mark · CIK 0001612372 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 657,895 Underlying: Common Stock · 657,895 shares Expires 2029-02-03 Read SEC document |
| January 15, 2019 Filed Jan 25, 2019 00:49 UTC |
Mayne Pharma Ventures Pty Ltd10% owner
Mayne Pharma International Pty Ltd10% owner
Mayne Pharma Group Ltd10% owner
|
OtherCommon Stock | 362,121 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-19-002698 · tv511589_4.xml · nonDerivative · entry 1 Mayne Pharma Ventures Pty Ltd · CIK 0001611535 · 10% owner Mayne Pharma International Pty Ltd · CIK 0001611534 · 10% owner Mayne Pharma Group Ltd · CIK 0001560183 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 198,653,051 F1 · kind: On January 15, 2019, Mayne Pharma Ventures Pty Ltd ("Mayne Ventures") received a dividend of 362,121 shares of Common Stock paid by the Issuer on shares of Series B Convertible Preferred Stock held by Mayne Ventures, pursuant to the terms of such Series B Convertible Preferred Stock. F2 · ownership.direct: These securities are directly owned by Mayne Ventures. This report is filed jointly by Mayne Ventures, Mayne Pharma International Pty Ltd ("Mayne International") and Mayne Pharma Group Limited ("Mayne Group"). Mayne Group holds 100% of the issued and outstanding equity securities of Mayne International, and Mayne International holds 100% of the issued and outstanding equity securities of Mayne Ventures. Consequently, Mayne Group and Mayne International may be deemed to beneficially own the securities that are the subject to this report indirectly, but disclaim beneficial ownership of such securities except to the extent of their pecuniary interests therein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, Mayne Ventures is deemed a director by deputization by virtue of its representation on the Board of Directors of the Issuer. Read SEC document |
| December 20, 2018 Filed Dec 26, 2018 22:15 UTC |
Martin Robert DanielDirector
|
GrantCommon Stock | 60,000 | $0.08 | $4,800.00 |
DisclosureSEC source: 0000899243-18-031719 · doc4.xml · nonDerivative · entry 1 Martin Robert Daniel · CIK 0001509322 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,000 Read SEC document |
| December 20, 2018 Filed Dec 26, 2018 22:15 UTC |
MAGRAB E. BRENDANDirector
|
GrantCommon Stock | 65,000 | $0.08 | $5,200.00 |
DisclosureSEC source: 0000899243-18-031718 · doc4.xml · nonDerivative · entry 1 MAGRAB E. BRENDAN · CIK 0001196062 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 Read SEC document |
| August 30, 2018 Filed Aug 31, 2018 20:30 UTC |
Hasara Garrison J.CFO and Treasurer
|
SaleCommon Stock | 100,000 | $0.27 | $27,000.00 |
DisclosureSEC source: 0000899243-18-023650 · doc4.xml · nonDerivative · entry 1 Hasara Garrison J. · CIK 0001510349 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,959,044 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.